Crossmark

Low advanced Glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s40200-020-00614-0

Published Online: 2020-08-26

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Goudarzi, Razieh

Sedaghat, Meghdad

Hedayati, Mehdi

Hekmatdoost, Azita

Sohrab, Golbon
Funding

Funding for this research was provided by:

National Nutrition and Food Technology Research Institute (675)
License Information

Text and Data Mining valid from 2020-08-26

Version of Record valid from 2020-08-26
More Information

Article History

Received: 9 October 2019

Accepted: 14 August 2020

First Online: 26 August 2020

Compliance with ethical standards

:

: <i>The authors declared that they have no conflict of interest.</i>

Document is current

Any future updates will be listed below